Brain Cancer

Glioblastoma of Brain Stem

Male, 32 years

Patient Internal 276057614

ICD-10 code

C71.7 Malignant Neoplasm of Brain Stem

Diagnosis (Incl. Metastases/Stage) and Year

May 2022
Glioblastoma of Brain Stem WHO Grade 3-4, IDH(-), ATRH(-), TP53(+), MGMT(-).

Previous Treatment

Surgery, Radiation Therapy and Chemotherapy (Temozolomide), Chemotherapy (Temozolomide), Chemotherapy (Lomustine).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~14 months from diagnosis.

Treatment Provided

Autologous DCV (7 doses) and CIK (4 doses) over a period of 7 months.

Patient Survival/Condition and Year
Date of Review: 07/02/2024

The patient survived for 13 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapy and Radiation Therapy, benefitted the patient in almost meeting the median survival, however did not extended patient survival.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok